Other specialties, such as oncology, benefit from dispensing medication directly from their medical practices, but what about rheumatology? Experts discussed two approaches to in-office dispensing, highlighting the financial benefits and positive impact on patients.
Latest News
NASP Reduces Tophi in Uncontrolled Gout
A post-hoc analysis of data from two clinical trials showed that nano-encapsulated sirolimus with pegylated-adricase (NASP) may be effective for promoting tophus resolution and lowering serum uric acid in patients with uncontrolled gout.
FDA Approves Obinutuzumab for Lupus Nephritis
Based on data from multiple clinical trials, the FDA has approved obinutuzumab for the treatment of adults with lupus nephritis in combination with standard therapy.
Hip Replacements at 14,000 Feet: A Joint Doctor with Joint Disease, Part 2
Dr. Sam Shapiro writes about her recovery from total hip arthroplasty, detailing what “recovering well with no post-operative complications” really meant and her experience hiking in the Himalayas with a new hip.
Clinical Manifestations of VEXAS
Anderson et al. studied genetic data on more than 190,000 participants and found 23 who had genetic variants in the UBA1 gene, which is associated with VEXAS.
RA Research Presented at ACR Convergence 2025 in Focus
This synopsis of research into rheumatoid arthritis highlights key areas presented at ACR Convergence 2025, including strategies to delay or prevent RA, emerging mechanisms of action in RA treatment, and the growing role of AI in advancing RA research and clinical care.
